IP Library Patent Application 19186886
Patent Application
App. No. 19/186,886

UTERINE HEMORRHAGE CONTROLLING SYSTEM AND METHOD

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
19/186,886
Abstract

An insertable device is designed to control uterine hemorrhaging after birth by facilitating contractile movement of the uterus. An insertable device comprises a tube having a connecting portion and a suction portion and a seal positioned along the length of the connecting portion proximal to the suction portion. Upon insertion of the suction portion and seal into the uterus, the seal abuts a vaginal canal and forms a seal between a vaginal opening and the uterus. The suction portion comprises a first loop having an opening that is oriented away from an interior wall of the uterus when inserted into the uterus. The connecting portion of the tube couples to a pump that when actuated generates a negative pressure within the uterus, resulting in a uniform mechanical stimulus to the uterine wall in order to facilitate tamponade and contractile movement of the tissue.

Claims (20)

1 . (canceled)

2 . An insertable device comprising:

a suction portion comprising a tube formed into a loop, the tube including a plurality of openings along a medial surface of the loop, the suction portion being configured for insertion into a uterus and to transmit a pressure change through the plurality of openings;

a seal connected adjacent to the suction portion, the seal being sized and configured to seal against a uterine wall to facilitate maintenance of the pressure change inside the uterus; and

a connecting portion wherein the tube is joined to itself at a connector proximal to the loop;

wherein application of the pressure change results in a uniform mechanical stimulus to the uterus in order to facilitate tamponade and contractile movement of the tissue.

3 . The insertable device of claim 2 , wherein the connector is attached to a proximal end of the connecting portion.

4 . The insertable device of claim 2 , wherein the connector includes a distal end sized and configured to receive the connecting portion wherein the tube is joined side-by-side to itself.

5 . The insertable device of claim 4 , wherein the connector includes proximal end defining a single lumen.

6 . The insertable device of claim 2 , wherein the connector ensures that the plurality of openings remain facing into the loop away from a uterine wall upon insertion to prevent obstruction of the openings.

7 . The insertable device of claim 2 , further including tubing connectable to a vacuum source extending from the proximal end of the connector.

8 . The insertable device of claim 2 , wherein the connecting portion comprises a single channel extending along a length of the connecting portion.

9 . The insertable device of claim 2 , wherein the tube is a single tube is folded to form the loop of suction portion and the connecting portion.

10 . The insertable device of claim 2 , wherein the seal is a circular or elliptical disk.

11 . The insertable device of claim 2 , wherein the seal is flexible and includes a lip around its perimeter to facilitate sealing against a uterine wall.

12 . The insertable device of claim 2 , wherein the seal has a concave profile.

13 . The insertable device of claim 2 , wherein the seal is an inflatable balloon.

14 . The insertable device of claim 13 , further including an inflation tube connected to the inflatable balloon for inflating the seal.

15 . The insertable device of claim 2 , wherein the seal is cup-shaped and flexible to allow the seal to conform to anatomy of a uterine wall.

16 . The insertable device of claim 2 , wherein the seal abuts a vaginal canal upon insertion of the insertable device and forms a seal between a vaginal opening and the uterus.

Assignments (1)
SECURITY INTEREST Recorded Feb 27, 2026
From: ALYDIA HEALTH, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 073924/0283 →